Literature DB >> 7496239

Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology).

D W Denning1, E G Evans, C C Kibbler, M D Richardson, M M Roberts, T R Rogers, D W Warnock, R E Warren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7496239      PMCID： PMC2551187          DOI： 10.1136/bmj.311.7015.1277

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview).

Authors:  M Zaug; M Bergstraesser
Journal:  Clin Exp Dermatol       Date:  1992-09       Impact factor: 3.470

2.  Antidiarrhoeal drugs for acute diarrhoea in children.

Authors:  A M Costello; T I Bhutta
Journal:  BMJ       Date:  1992-01-04

3.  Fungi in nails.

Authors:  M M Walshe; M P English
Journal:  Br J Dermatol       Date:  1966-04       Impact factor: 9.302

4.  Psoriasis of the nail. A clinical-pathologic study.

Authors:  N Zaias
Journal:  Arch Dermatol       Date:  1969-05

Review 5.  The epidemiology of onychomycosis in Britain.

Authors:  H C Williams
Journal:  Br J Dermatol       Date:  1993-08       Impact factor: 9.302

6.  The treatment of fungus and yeast infections of nails by the method of "chemical removal'.

Authors:  M I White; Y M Clayton
Journal:  Clin Exp Dermatol       Date:  1982-05       Impact factor: 3.470

Review 7.  Fungal infections of the nail.

Authors:  E Haneke
Journal:  Semin Dermatol       Date:  1991-03

8.  Terbinafine in onychomycosis with involvement by non-dermatophytic fungi.

Authors:  S Nolting; M Brautigam; G Weidinger
Journal:  Br J Dermatol       Date:  1994-04       Impact factor: 9.302

9.  Foot infections in swimming baths.

Authors:  J C Gentles; E G Evans
Journal:  Br Med J       Date:  1973-08-04

10.  Chronic paronychia and psoriasis.

Authors:  S Ganor
Journal:  Br J Dermatol       Date:  1975-06       Impact factor: 9.302
View more
  14 in total

1.  Inappropriate use of oral terbinafine in family practice.

Authors:  Michael Wilcock; John Hartley; David Gould
Journal:  Pharm World Sci       Date:  2003-02

2.  Risk factors for candida infection of the genital tract in the tropics.

Authors:  Na Dou; Weiping Li; Enfeng Zhao; Chan Wang; Zhaozhao Xiao; Honghui Zhou
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

3.  Evaluation of pan-dermatophyte nested PCR in diagnosis of onychomycosis.

Authors:  Jaya Garg; Ragini Tilak; Sanjay Singh; Anil Kumar Gulati; Atul Garg; Pradyot Prakash; Gopal Nath
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

4.  New strategies in the management of onychomycosis.

Authors:  A K Gupta
Journal:  West J Med       Date:  1996-06

Review 5.  A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.

Authors:  A K Gupta; N H Shear
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

6.  A rare case of onychomycosis in all 10 fingers of an immunocompetent patient.

Authors:  Asima Banu; Mridu Anand; L Eswari
Journal:  Indian Dermatol Online J       Date:  2013-10

7.  [Fungal nail infections - an update. Part 2 - From the causative agent to diagnosis - conventional and molecular procedures].

Authors:  P Nenoff; G Ginter-Hanselmayer; H-J Tietz
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

Review 8.  Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.

Authors:  V N Joish; E P Armstrong
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 9.  Terbinafine. An update of its use in superficial mycoses.

Authors:  K J McClellan; L R Wiseman; A Markham
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

Review 10.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.

Authors:  M Haria; H M Bryson; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.